https://www.business-standard.com/article/companies/bharat-biotech-to-begin-trials-of-intranasal-vaccine-for-covid-in-feb-mar-121010800340_1.html
The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit
Bharat Biotech to begin trials of intranasal vaccine for Covid in Feb-Mar
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- United States 4-Week Bill Auction: 4.53% vs 4.51%
- Nvidia stock surges and crashes as bulls, bears fight over meaning of Q3 results
- EUR/CAD Price Analysis: Pair fell below 1.4700, lowest since July
- Pound Sterling Price News and Forecast: GBP/USD drops on risk-aversion, sellers eye 1.2600
- United States Kansas Fed Manufacturing Activity declined to -4 in November from previous 0
- Reclaiming tax transparency from the angry right
- Look beyond the domestic rows, and George Osborne is planning a budget aimed squarely at multi-nationals and footloose capital
- Ever closer together, rarely as far apart
- The evolving western plan for Syria
- For once, an American president uses a British prime minister for a photo-op
More from UncategorizedMore posts in Uncategorized »
- These tips for investing in mutual funds and ETFs help build a strong portfolio
- United States 4-Week Bill Auction: 4.53% vs 4.51%
- Nvidia stock surges and crashes as bulls, bears fight over meaning of Q3 results
- EUR/CAD Price Analysis: Pair fell below 1.4700, lowest since July
- Pound Sterling Price News and Forecast: GBP/USD drops on risk-aversion, sellers eye 1.2600
- United States Kansas Fed Manufacturing Activity declined to -4 in November from previous 0
- Reclaiming tax transparency from the angry right
- Look beyond the domestic rows, and George Osborne is planning a budget aimed squarely at multi-nationals and footloose capital
- Ever closer together, rarely as far apart
- The evolving western plan for Syria
